Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325, 1074–1087 (2021).

Article  CAS  PubMed  Google Scholar 

Greene, A. G., Saleh, M., Roseman, E. & Sinert, R. Toxic shock-like syndrome and COVID-19: multisystem inflammatory syndrome in children (MIS-C). Am. J. Emerg. Med. 38, 2492.e5–2492.e6 (2020).

Article  PubMed  Google Scholar 

Wessels, P. A. & Bingler, M. A. A comparison of Kawasaki disease and multisystem inflammatory syndrome in children. Prog. Pediatr. Cardiol. 65, 101516 (2022).

Article  PubMed Central  Google Scholar 

Sperotto, F. et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur. J. Pediatr. 180, 307–322 (2021).

Article  CAS  PubMed  Google Scholar 

Kwak, J. H., Lee, S.-Y. & Choi, J.-W. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019. Clin. Exp. Pediatr. 64, 68–75 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Whittaker, E. et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324, 259–269 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vella, L. A. et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19. Sci. Immunol. https://www.science.org/doi/10.1126/sciimmunol.abf7570. Accessed 3 May 2023.

Consiglio, C. R. et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183, 968–981.e7 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolahian, S. et al. The emerging role of myeloid-derived suppressor cells in lung diseases. Eur. Respir. J. 47, 967–977 (2016).

Article  CAS  PubMed  Google Scholar 

Glover, A., Zhang, Z. & Shannon-Lowe, C. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis. Front. Immunol. 14, 1161848 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bline, K. et al. Myeloid-derived suppressor cells and clinical outcomes in children with COVID-19. Front. Pediatr. 10, 893045. https://www.frontiersin.org/article/10.3389/fped.2022.893045 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Bline, K. E. et al. Novel Identification of Myeloid-Derived Suppressor Cells in Children With Septic Shock. Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intensive Crit. Care Soc. 23, e555–e563 (2022).

Google Scholar 

Porritt, R. A. et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J. Clin. Investig. 131, e151520 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

CDC. Multisystem Inflammatory Syndrome (MIS). Centers for Disease Control and Prevention, https://www.cdc.gov/mis/mis-c/hcp/index.html (2020).

Pollack, M. M., Patel, K. M. & Ruttimann, U. E. PRISM III: an updated pediatric risk of mortality score. Crit. Care Med. 24, 743–752 (1996).

Article  CAS  PubMed  Google Scholar 

Leteurtre, S. et al. PELOD-2: an update of the pediatric logistic organ dysfunction score. Crit. Care Med. 41, 1761–1773 (2013).

Article  PubMed  Google Scholar 

Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 383, 334–346 (2020).

Article  CAS  PubMed  Google Scholar 

Apodaca, M. C. et al. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells. J. Immunother. Cancer 7, 230 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Diaz-Montero, C. M. et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49–59 (2009).

Article  CAS  PubMed  Google Scholar 

Thiele, C. & Hirschfeld, G. cutpointr: improved estimation and validation of optimal cutpoints in R. J. Stat. Softw. 98, 1–27, www.jstatsoft.org (2021).

Article  Google Scholar 

R: The R Project for Statistical Computing. https://www.r-project.org/. Accessed 18 July 2023.

Quintero, A. M. et al. Differences in SARS-CoV-2 clinical manifestations and disease severity in children and adolescents by infecting variant. Emerg. Infect. Dis. 28, 2270–2280 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Corwin, D. J. et al. Distinguishing multisystem inflammatory syndrome in children from Kawasaki disease and benign inflammatory illnesses in the SARS-CoV-2 pandemic. Pediatr. Emerg. Care 36, 554–558 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Noval Rivas, M., Porritt, R. A., Cheng, M. H., Bahar, I. & Arditi, M. Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis. Front. Immunol. 13, 941009 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Carter, M. J. et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat. Med. 26, 1701–1707 (2020).

Article  CAS  PubMed  Google Scholar 

Rajamanickam, A. et al. Unique cellular immune signatures of multisystem inflammatory syndrome in children. PLoS Pathog. 18, e1010915 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boribong, B. P. et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children. Cell Rep. Med. 3, 100848 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruan, W.-S. et al. Early activation of myeloid-derived suppressor cells participate in sepsis-induced immune suppression via PD-L1/PD-1 Axis. Front. Immunol. 11, 1299 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Köstlin-Gille, N. & Christian, G. Myeloid-derived suppressor cells in pregnancy and the neonatal period. Front. Immunol. 11, 584712 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Passive transfer of tumour‐derived MDSCs inhibits asthma‐related airway inflammation. Scand. J. Immunol. Wiley Online Library. https://onlinelibrary.wiley.com/doi/full/10.1111/sji.12140. Accessed 7 Sept. 2022.

van Geffen, C. et al. Myeloid-derived suppressor cells dampen airway inflammation through prostaglandin E2 receptor 4. Front. Immunol. 12, 695933 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Yang, F. et al. The effect of immunosuppressive drugs on MDSCs in transplantation. J. Immunol. Res. 3, 5414808 (2018).

Google Scholar 

Simón-Fuentes, M. et al. Intravenous immunoglobulins promote an expansion of monocytic myeloid-derived suppressor cells (MDSC) in CVID patients. J. Clin. Immunol. 42, 1093–1105 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Cheng, R. et al. Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells. Oncogene 39, 1543–1556, www.nature.com (2020).

Article  CAS  PubMed  Google Scholar